My first post...ever, anywhere, so bear with me. I have been following GTCB for about a year and a half, so understandably my patience has not been worn as thin as many of you that post on this board. However, I would like to make one observation before heading off to class.
My interest in GTCB is personal. My wife is a carrier of hemophilia. While she does not express the illness, our boys may and our girls have a 50/50 chance of carrying. The men in her family, her brother, have been affected by the illness both in limiting there activities, but also in sudden, life-threatening "bleeding" episodes.
As such, I am willing to be patient for a treatment that is affordable, effective, and safe. I feel in reading both the personal and professional histories of the executives, researchers, clinicians and employees of GTCB that they possess these very quality - a focus on making sure their products are affordable, effective, and safe. I do not know of a better formula for drugs than that.
Now my observation...let's be honest, most people that invest want to make money, correct? So, it is not surprise that after seven years of disappointment that we all mistakenly want our investments to bear fruit. However, this is not the quality of this company. They have qualities that are necessary for their products. Their technology is revolutionary, it faces headwinds that most drugs do not - Big Pharma, FDA, EMEA regulations and laws that need to change - not to mention the stigma of drugs from genetically modified organisms...all of these things go against the collective conscience of the public and the drug companies that provide them.
My point...MOST drug companies want to make money too...not a difference. I believe the likes of Meade and Cox want to make a difference. Ask yourselves the right questions? Do I believe in the technology? Most importantly, do they? Is the technology sound? Is the technology conducive to this new era of sky rocketing health care...meaning, is it advantageous, competitive, and able to provide on a large scale? As such, do you believe the value of the company is increasing no that the technology platform (OUR FOCUS, as is theirs) is proven? Lastly, has the technology been proven? I would say that the answer to all of these questions is YES.
So, please, if your desire is to make money first, not later. Go somewhere else. i promise you the last thing these guys think about is the current stock value. They are focused on the goal, not the whinings of seemingly impatient (although understandable)
investors. The current financing is indeed not dilutive if it creates value...it's all a matter of focus and perspective...
GTCB is a group of committed, very intelligent, patient people. A quality that most do not possess. They will prevail...so be patient and do your dew deligence where it belongs...the technology, the demand (market), the competition, and the ability for GTCB to meet and beat those criteria...the money and financing will follow as those barriers are broken...just be patient, as are they. Is that not what we want? people that believe in what they are doing and don't give up...to me, that's why GTCB is special and that's why I have my money on them.
That is all...
AI
Market Data 
Markets 
